As of June 18, 2026, Lexeo Therapeutics's top three insider holders are Capital Partners Iv, Llc Longitude (TenPercentOwner, 2.57Mn shares), Fund Vi, L.P. Omega (TenPercentOwner, 2.16Mn shares), Invest A/S Lundbeckfond (TenPercentOwner, 1.84Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Paula H Cholmondeley | - | 30,627 | 0 | 26 Nov, 2024 |
| Invest A/S Lundbeckfond | - | 1,835,959 | 0 | 09 Nov, 2023 |
| Fund Vi, L.P. Omega | - | 2,157,623 | 0 | 09 Nov, 2023 |
| Capital Partners Iv, Llc Longitude | - | 0 | 2,567,100 | 09 Nov, 2023 |
| Eric Adler | Chief Medical Officer | 72,646 | 0 | 20 Nov, 2025 |
| Paul Mccormac | Chief Technical Officer | 17,349 | 0 | 09 Nov, 2023 |
| Jenny Robertson | Chief Legal Officer | 68,381 | 0 | 20 Nov, 2025 |
| Richard Nolan Townsend | Chief Executive Officer | 340,106 | 0 | 07 Apr, 2026 |
| Tai Sandi See | Chief Development Officer | 65,476 | 0 | 20 Nov, 2025 |
| Jose Manuel Otero | Chief Operating Officer | 131,390 | 0 | 17 Mar, 2026 |
| Kyle Rasbach | Chief Financial Officer | 40,875 | 0 | 22 Jan, 2025 |
| Louis Edward Tamayo | Chief Financial Officer | 89,665 | 0 | 06 Feb, 2026 |
| Narinder Pal Bhalla | Chief Medical Officer | 49,500 | 0 | 17 Feb, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 06 Apr, 2026 | Richard Nolan Townsend | Common Stock | D | 55,000 | $5.69 | 340,106 | D | S |
| 06 Apr, 2026 | Richard Nolan Townsend | Common Stock | D | 55,000 | $5.69 | 340,106 | D | S |
| 13 Mar, 2026 | Jose Manuel Otero | Common Stock | A | 5,930 | $2.64 | 131,390 | D | A |
| 13 Mar, 2026 | Richard Nolan Townsend | Common Stock | A | 2,623 | $2.64 | 395,106 | D | A |
| 13 Mar, 2026 | Richard Nolan Townsend | Common Stock | A | 2,623 | $2.64 | 395,106 | D | A |
| 13 Mar, 2026 | Jose Manuel Otero | Common Stock | A | 5,930 | $2.64 | 131,390 | D | A |
| 13 Mar, 2026 | Richard Nolan Townsend | Common Stock | A | 2,623 | $2.64 | 395,106 | D | A |
| 13 Mar, 2026 | Jose Manuel Otero | Common Stock | A | 5,930 | $2.64 | 131,390 | D | A |
| 18 Feb, 2026 | Richard Nolan Townsend | Common Stock | D | 10,173 | $6.38 | 392,483 | D | S |
| 18 Feb, 2026 | Richard Nolan Townsend | Common Stock | D | 10,173 | $6.38 | 392,483 | D | S |
| 18 Feb, 2026 | Jose Manuel Otero | Common Stock | D | 3,016 | $6.40 | 125,460 | D | S |
| 18 Feb, 2026 | Jose Manuel Otero | Common Stock | D | 3,016 | $6.40 | 125,460 | D | S |
| 18 Feb, 2026 | Jose Manuel Otero | Common Stock | D | 3,016 | $6.40 | 125,460 | D | S |
| 18 Feb, 2026 | Richard Nolan Townsend | Common Stock | D | 10,173 | $6.38 | 392,483 | D | S |
| 13 Feb, 2026 | Narinder Pal Bhalla | Common Stock | A | 49,500 | $0.00 | 49,500 | D | A |
| 13 Feb, 2026 | Narinder Pal Bhalla | Stock Option (right to buy) | A | 297,000 | $0.00 | 297,000 | D | A |
| 04 Feb, 2026 | Louis Edward Tamayo | Common Stock | A | 44,665 | $0.00 | 89,665 | D | A |
| 04 Feb, 2026 | Jose Manuel Otero | Common Stock | A | 65,000 | $0.00 | 128,476 | D | A |
| 04 Feb, 2026 | Jose Manuel Otero | Common Stock | A | 65,000 | $0.00 | 128,476 | D | A |
| 04 Feb, 2026 | Richard Nolan Townsend | Common Stock | A | 161,665 | $0.00 | 402,656 | D | A |